Herbas VPB

Print
EN | LT
LT - Metastazių smegenyse gydymas endotelino receptorių inhibitoriais, derinyje su citotoksiniu chemoterapiniu agentu
EN - TREATMENT OF BRAIN METASTASES WITH INHIBITORS OF ENDOTHELIN RECEPTORS IN COMBINATION WITH A CYTOTOXIC CHEMOTHERAPY AGENT

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A01K 67/00 (2006.01)
A61K 31/337 (2006.01)
A61K 31/4188 (2006.01)
A61K 31/506 (2006.01)
C12N 5/00 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 2464218
(13) Kind of document T
(96) European patent application number 10742690.0
Date of filing the European patent application 2010-08-09
(97) Date of publication of the European application 2012-06-20
(45) Date of publication and mention of the grant of the patent 2015-05-27
(46) Date of publication of the claims translation 2015-10-26
PCT application
(86) Number PCT/US2010/044832
Date 2010-08-09
PCT application publication
(87) Number WO 2011/019630
Date 2011-02-17
Priority applications
(30) Number Date Country code
232687 P 2009-08-10 US
Inventors
(72)
FIDLER, Isaiah, J., US
KIM, Sun-jin, US
Grantee
(73) Board of Regents, The University of Texas System, 201 West Seventh Street, Austin, TX 78701, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Metastazių smegenyse gydymas endotelino receptorių inhibitoriais, derinyje su citotoksiniu chemoterapiniu agentu
  TREATMENT OF BRAIN METASTASES WITH INHIBITORS OF ENDOTHELIN RECEPTORS IN COMBINATION WITH A CYTOTOXIC CHEMOTHERAPY AGENT
Last renewal fee
Payment date Validity (years) Amount
2015-07-30 6 139.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2016-08-09